These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 32009529)
1. Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction. Prenner SB; Pillutla R; Yenigalla S; Gaddam S; Lee J; Obeid MJ; Ans AH; Jehangir Q; Kim J; Zamani P; Mazurek JA; Akers SR; Chirinos JA J Am Heart Assoc; 2020 Feb; 9(3):e014716. PubMed ID: 32009529 [TBL] [Abstract][Full Text] [Related]
2. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction. Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227 [TBL] [Abstract][Full Text] [Related]
3. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction. Roy C; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC J Cardiovasc Magn Reson; 2018 Aug; 20(1):55. PubMed ID: 30086783 [TBL] [Abstract][Full Text] [Related]
4. Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction. Chirinos JA; Bhattacharya P; Kumar A; Proto E; Konda P; Segers P; Akers SR; Townsend RR; Zamani P J Am Heart Assoc; 2019 Feb; 8(4):e011457. PubMed ID: 30764699 [TBL] [Abstract][Full Text] [Related]
5. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction. Bolat I; Biteker M Scand Cardiovasc J; 2020 Jun; 54(3):174-178. PubMed ID: 31965867 [No Abstract] [Full Text] [Related]
6. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction. Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742 [TBL] [Abstract][Full Text] [Related]
7. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study. Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408 [TBL] [Abstract][Full Text] [Related]
8. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome. Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645 [TBL] [Abstract][Full Text] [Related]
9. Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction. Menghoum N; Badii MC; Deltombe M; Lejeune S; Roy C; Vancraeynest D; Pasquet A; Gerber BL; Horman S; Gruson D; Beauloye C; Pouleur AC ESC Heart Fail; 2024 Jun; 11(3):1493-1505. PubMed ID: 38339764 [TBL] [Abstract][Full Text] [Related]
10. Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome. Schelbert EB; Fridman Y; Wong TC; Abu Daya H; Piehler KM; Kadakkal A; Miller CA; Ugander M; Maanja M; Kellman P; Shah DJ; Abebe KZ; Simon MA; Quarta G; Senni M; Butler J; Diez J; Redfield MM; Gheorghiade M JAMA Cardiol; 2017 Sep; 2(9):995-1006. PubMed ID: 28768311 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-HFpEF Registry. Seo M; Yamada T; Tamaki S; Hikoso S; Yasumura Y; Higuchi Y; Nakagawa Y; Uematsu M; Abe H; Fuji H; Mano T; Nakatani D; Fukunami M; Sakata Y J Am Heart Assoc; 2020 Jan; 9(1):e014100. PubMed ID: 31847660 [TBL] [Abstract][Full Text] [Related]
12. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Krum H; Elsik M; Schneider HG; Ptaszynska A; Black M; Carson PE; Komajda M; Massie BM; McKelvie RS; McMurray JJ; Zile MR; Anand IS Circ Heart Fail; 2011 Sep; 4(5):561-8. PubMed ID: 21750125 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Nutritional Index and the Risk of Mortality in Patients With Acute Heart Failure. Cheng YL; Sung SH; Cheng HM; Hsu PF; Guo CY; Yu WC; Chen CH J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649089 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes prediction in diabetic heart failure with preserved ejection fraction by cardiac MRI. Yang W; Zhu L; He J; Wu W; Zhang Y; Zhuang B; Xu J; Zhou D; Wang Y; Liu G; Sun X; Zhang Q; Sirajuddin A; Arai AE; Zhao S; Lu M Eur Radiol; 2024 Sep; 34(9):5678-5690. PubMed ID: 38421414 [TBL] [Abstract][Full Text] [Related]
15. Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction. Kresoja KP; Rommel KP; Fengler K; von Roeder M; Besler C; Lücke C; Gutberlet M; Desch S; Thiele H; Böhm M; Lurz P Circ Heart Fail; 2021 Mar; 14(3):e007421. PubMed ID: 33706547 [TBL] [Abstract][Full Text] [Related]
16. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization. Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171 [TBL] [Abstract][Full Text] [Related]
17. Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial. Myhre PL; Vaduganathan M; Claggett BL; Anand IS; Sweitzer NK; Fang JC; O'Meara E; Shah SJ; Desai AS; Lewis EF; Rouleau J; Pitt B; Pfeffer MA; Solomon SD JAMA Cardiol; 2018 Oct; 3(10):1000-1005. PubMed ID: 30140899 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490 [TBL] [Abstract][Full Text] [Related]
19. Heart Failure with Normal Natriuretic Peptide Levels and Preserved Ejection Fraction: A Prospective Clinical and Cardiac MRI Study. He J; Yang W; Wu W; Yin G; Zhuang B; Xu J; Zhou D; Zhang J; Wang Y; Zhu L; Sun X; Sirajuddin A; Teng Z; Kureshi F; Arai AE; Zhao S; Lu M Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230281. PubMed ID: 38695743 [TBL] [Abstract][Full Text] [Related]
20. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction. Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]